October 17, 2025 Where Renal Cancer Strikes Hardest – and Why the Numbers Are Climbing Fast Global analysis reveals sharp rises in incidence, survival gaps across regions, and key genetic risk factors shaping diagnostics The Pathologist
October 14, 2025 LDTs: The Hidden Engines of Precision Medicine How LDTs give labs the agility to innovate beyond red tape – and deliver critical answers when patients need them most The Pathologist
October 10, 2025 Seaport Criteria Bring Clarity to Myocarditis Grading New guidelines combine hematoxylin and eosin and CD3 staining to improve diagnostic accuracy and reproducibility worldwide The Pathologist
October 08, 2025 Tracking Residual Disease in Myeloma With Flow Cytometry Multiparameter flow cytometry enables measurable residual disease testing and prognosis in patients with multiple myeloma The Pathologist
October 07, 2025 Spatial Proteomics in Cancer Risk Predictions AI-powered test enhances progression risk assessment in esophageal cancer The Pathologist
September 30, 2025 Surrogates with Substance: Decoding Soft Tissue Tumors Following a new CAP review, Jason L. Hornick discusses the strengths – and limitations – of IHC as a stand-in for molecular testing The Pathologist
September 26, 2025 Prostate Cancer Screening Is Broken – How Do We Fix It? Changing guidelines and flawed PSA thresholds have left men uncertain, but modern testing can restore confidence The Pathologist
September 25, 2025 New Rules Aim to Standardize HRD Testing in Cancer Labs Consensus recommendations standardize homologous recombination deficiency testing for clinical molecular laboratories The Pathologist
September 24, 2025 Recent Advances in Treating Diffuse Large B-Cell Lymphoma The disease we now call diffuse large B-cell lymphoma (DLBCL) has gone by the names of reticulum cell sarcoma, diffuse histiocytic lymphoma, and diffuse large cell lymphoma and included both lymphomas... The ASCO Post